Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/18/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Martha Sajatovic

Wrong Dr. Martha Sajatovic?

Director, Neurological and Behavi...

Phone: (216) ***-****  
Email: m***@***.org
University Hospitals of Cleveland
11100 Euclid Avenue MCCO Building - 5062
Cleveland , Ohio 44106
United States

Company Description: University Hospitals Health System is the region's premier health care delivery system, serving patients at more than 150 locations throughout northern Ohio.

Employment History

Board Memberships and Affiliations


  • M.D.
  • B.D. , biology
    Ohio State University
  • Medical College of Ohio at Toledo
68 Total References
Web References
David J. Muzina, MD and Martha ... [cached]
David J. Muzina, MD and Martha Sajatovic, MD
Dr Sajatovic is professor of psychiatry at Case Western Reserve University School of Medicine in Cleveland and director of geropsychiatry at University Hospitals Case Medical Center in Cleveland. Dr Muzina reports that he is on the speakers' bureau for AstraZeneca, Bristol-Myers Squibb, Pfizer, Sepracor, and Wyeth; and that he is a member of the scientific advisory board for AstraZeneca. Dr Sajatovic reports that she has received research funding from AstraZeneca, GlaxoSmithKline, and the NIMH; and she is a consultant for GlaxoSmithKline, Cognition Group, and AstraZeneca.
DBSA Scientific Advisory Board - Depression and Bipolar Support Alliance, 1 June 2015 [cached]
Martha Sajatovic, MD Director, Geriatric Psychiatry Research University Hospitals of Cleveland
"The overall results, that substantially ... [cached]
"The overall results, that substantially more individuals are on psychotropic medications is sobering and important.  Understanding the reasons for this increase is the next critical goal," said Dr. Martha Sajatovic, Professor of Psychiatry at Case Western Reserve University School of Medicine and Director of the Neurological Outcomes Center, University Hospitals Case Medical Center.  "The health care implications could be substantial given increasing financial constraints on individuals and health care funding entities."
United BioSource Corporation, 2 Mar 2008 [cached]
Martha Sajatovic, M.D.
Martha Sajatovic, M.D.Associate Professor of PsychiatryCase Western University School of Medicine
Dr. Sajatovic is a researcher, educator and clinician who has devoted herself to the study and treatment of traditionally hard-to treat populations with serious mental illness.
Dr. Sajatovic received her B.D. in biology at Ohio State University and completed medical school at the Medical College of Ohio at Toledo.Dr. Sajatovic completed her residency training in psychiatry at University Hospitals of Cleveland where she was Chief Resident in Research.Following completion of her residency, Dr. Sajatovic was Clinical Director of Inpatient Schizophrenia Research at University Hospitals of Cleveland and later was Associate Chief of Psychiatry and Chief of the Mood Disorders Program at the Cleveland Veterans Affairs Medical Center in Cleveland, Ohio.She has been Chief Clinical Officer of an acute care state-funded facility, NorthCoast Behavioral HealthCare, and currently practices Geropsychiatry at University Hospitals of Cleveland.
Quetiapine Improves ~Psychosis-Related Symptoms, 15 April 2001 [cached]
Although they might not be as obvious to the outside world as hallucinations and delusions , depressive symptoms can be just as devastating for patients suffering from psychosis , according to investigator Martha Sajatovic , MD , assistant professor of medicine in the Department of Psychiatry at Case Western Reserve University School of Medicine , Cleveland.This study demonstrates that quetiapine fumarate offers patients improvement in the symptoms of psychosis and may allow these patients to live a more normal life.A compound that may affect both the mood symptoms and the psychotic symptoms is very promising..
Commenting on the three studies , Dr. Sajatovic said , These studies are very interesting and intriguing , and they suggest that this drug may hold some promise for these patients..But she pointed out the need to consider that these are preliminary studies , and that longer , controlled trials need to be done to definitely prove this..
All three studies were supported by AstraZeneca Pharmaceuticals.
-Sarah Tilyou
This article is derived from the McMahon Archives.This information may be time sensitive and was archived on 9/7/2000.
Other People with the name "Sajatovic":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.